tirzepatide phase 2 obesity for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide for type 1 diabetes

Your prescriber might suggest: Reviewing your dietary habits and activity levels Checking for factors that could be interfering (medication interactions, stress, sleep) Continuing at 15 mg for longer some patients see renewed progress after a temporary stall Considering combination approaches or alternative treatments if Mounjaro alone isn't sufficient Managing side effects at each dose level Side effects are dose-dependent, which is one of the main reasons for the gradual titration schedule

However, animal studies indicate that they could be harmful to the developing fetus

Not animal-derived

Improved Blood Sugar Control Uncontrolled diabetes can damage nerves and blood vessels over time

Safety Profile Breakdown Common Side Effects : Phentermine : Dry mouth (30-40% of users) Insomnia (15-20%) Constipation (10-15%) Adderall : Appetite suppression (80-90%) Insomnia (30-40%) Anxiety (20-25%) Serious Risks : Phentermine : Pulmonary hypertension (rare) Valvular heart disease (very rare with modern formulations) Adderall : Cardiovascular events Psychiatric complications High abuse potential Cost and Accessibility Analysis Phentermine : Average monthly cost: $20-$50 (generic) Insurance coverage: Often covered for obesity treatment Prescription requirements: Schedule IV (less restrictive) Adderall : Average monthly cost: $150-$300 (generic) Insurance coverage: Rarely covered for weight loss Prescription requirements: Schedule II (strict controls) Practical Guidance for Patients Considering These Medications Who Should Consider Phentermine